Literature DB >> 24909210

Japanese guidelines for the management of pemphigus.

Masayuki Amagai, Akiko Tanikawa, Tomoko Shimizu, Takashi Hashimoto, Shigaku Ikeda, Michiko Kurosawa, Hironori Niizeki, Yumi Aoyama, Keiji Iwatsuki, Yasuo Kitajima.   

Abstract

The Committee for Guidelines for the Management of Pemphigus was organized as one element of the Japanese Dermatological Association (JDA) and the Ministry of Health, Labour, and Welfare (MHLW) Research Project on Measures for Research Committee for Intractable Skin Disease. Pemphigus has been defined as a group of intractable autoimmune blistering diseases caused by anti-desmoglein 1 and/or anti-desmoglein 3 IgG autoantibodies by the MHLW. The diagnosis of this condition and the criteria for assessing its severity are based on suggestions from the MHLW Research Group. The clinical practice guidelines presented here are those that are currently recommended in Japan. However, symptoms and complications can vary widely among individual pemphigus patients, so not all therapies will be required to be in complete agreement with these guidelines.
© 2014 Japanese Dermatological Association.

Entities:  

Keywords:  autoantibody; desmoglein; diagnosis; therapy

Mesh:

Year:  2014        PMID: 24909210     DOI: 10.1111/1346-8138.12486

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  14 in total

Review 1.  Pemphigus.

Authors:  Michael Kasperkiewicz; Christoph T Ellebrecht; Hayato Takahashi; Jun Yamagami; Detlef Zillikens; Aimee S Payne; Masayuki Amagai
Journal:  Nat Rev Dis Primers       Date:  2017-05-11       Impact factor: 52.329

2.  Diagnosis and management of pemphigus: Recommendations of an international panel of experts.

Authors:  Dedee F Murrell; Sandra Peña; Pascal Joly; Branka Marinovic; Takashi Hashimoto; Luis A Diaz; Animesh A Sinha; Aimee S Payne; Maryam Daneshpazhooh; Rüdiger Eming; Marcel F Jonkman; Daniel Mimouni; Luca Borradori; Soo-Chan Kim; Jun Yamagami; Julia S Lehman; Marwah Adly Saleh; Donna A Culton; Annette Czernik; John J Zone; David Fivenson; Hideyuki Ujiie; Katarzyna Wozniak; Ayşe Akman-Karakaş; Philippe Bernard; Neil J Korman; Frédéric Caux; Kossara Drenovska; Catherine Prost-Squarcioni; Snejina Vassileva; Ron J Feldman; Adela Rambi Cardones; Johann Bauer; Dimitrios Ioannides; Hana Jedlickova; Francis Palisson; Aikaterini Patsatsi; Soner Uzun; Savas Yayli; Detlef Zillikens; Masayuki Amagai; Michael Hertl; Enno Schmidt; Valeria Aoki; Sergei A Grando; Hiroshi Shimizu; Sharon Baum; Guiseppe Cianchini; Claudio Feliciani; Pilar Iranzo; Jose M Mascaró; Cezary Kowalewski; Russell Hall; Richard Groves; Karen E Harman; M Peter Marinkovich; Emanual Maverakis; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2018-02-10       Impact factor: 11.527

3.  Pemphigus Vulgaris: A Clinical Study of 31 Cases (2004-2014) in Morocco.

Authors:  Titou Hicham; Fatima Zahra Chahnoun; Tarik Hanafi; Naoufal Hjira; Boui Mohammed
Journal:  Dermatol Res Pract       Date:  2020-09-08

4.  Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study.

Authors:  Xingli Zhou; Liangliang Cheng; Yiyi Wang; Hui Gou; Ke Ju; TianJiao Lan; Tongying Zhan; GaoJie Li; Yuanxia Gu; Yeting Sun; Yan Xu; Yukun Sun; Yanhong Zhou; Wei Li
Journal:  J Dermatol       Date:  2021-12-05       Impact factor: 3.468

5.  Increased miR-424-5p expression in peripheral blood mononuclear cells from patients with pemphigus.

Authors:  Menglei Wang; Liuping Liang; Li Li; Kai Han; Qian Li; Yusheng Peng; Xuebiao Peng; Kang Zeng
Journal:  Mol Med Rep       Date:  2017-04-03       Impact factor: 2.952

6.  Features and associated factors of bacterial skin infections in hospitalized patients with pemphigus: a single-center retrospective study.

Authors:  Furong Li; Yejun Wu; Wenjie Bian; Lei Huang; Xuejun Zhu; Xixue Chen; Mingyue Wang
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-10-08       Impact factor: 3.944

7.  Abnormal uterine bleeding induced by glucocorticoid treatment for pemphigus. Case series and proposed treatment algorithm.

Authors:  Xiaobo Luo; Hui Feng; Lu Jiang; Qianming Chen
Journal:  Saudi Med J       Date:  2016-09       Impact factor: 1.484

Review 8.  Recent advances in the understanding and treatment of pemphigus and pemphigoid.

Authors:  Jun Yamagami
Journal:  F1000Res       Date:  2018-08-30

9.  Chromosome 2q33genetic polymorphisms in Tunisian endemic pemphigus foliaceus.

Authors:  Olfa Abida; Emna Bahloul; Mariem Ben Jmaa; Khadija Sellami; Ferjani Zouidi; Raouia Fakhfakh; Nadia Mahfoudh; Hamida Turki; Hatem Masmoudi
Journal:  Mol Genet Genomic Med       Date:  2020-09-01       Impact factor: 2.183

Review 10.  Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies.

Authors:  Haiqin Zhu; Meng Pan; Wenzhe Zhao; Jingying Wang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.